(225)Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic

The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of (177)Lu-radiolabeled somatostatin analogs. These radiopharmaceuticals have especially improved progression-free survival and qual...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubira, Léa, Deshayes, Emmanuel, Santoro, Lore, Kotzki, Pierre Olivier, Fersing, Cyril
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146019/
https://www.ncbi.nlm.nih.gov/pubmed/37111537
http://dx.doi.org/10.3390/pharmaceutics15041051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146019/
https://www.ncbi.nlm.nih.gov/pubmed/37111537
http://dx.doi.org/10.3390/pharmaceutics15041051

Ejemplares similares